{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T08:28:43Z","timestamp":1715588923407},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,10]]},"DOI":"10.7759\/cureus.21073","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T13:04:27Z","timestamp":1641819867000},"source":"Crossref","is-referenced-by-count":1,"title":["Outcome of Treatment in Children With Chronic Viral Hepatitis C: A Single Centre Study"],"prefix":"10.7759","author":[{"given":"Amima","family":"Usman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iqtadar","family":"Seerat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana Batool","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Sheraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafiz Aamir","family":"Yousaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1098\/rsos.180257","article-title":"The epidemiology of hepatitis C virus in Pakistan: systematic review and meta-analyses","volume":"5","author":"Al Kanaani Z","year":"2018","unstructured":"Al Kanaani Z, Mahmud S, Kouyoumjian SP, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Pakistan: systematic review and meta-analyses. R Soc Open Sci. 2018, 5:180257. 10.1098\/rsos.180257","journal-title":"R Soc Open Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i44.7880","article-title":"Burden of pediatric hepatitis C","volume":"19","author":"El-Shabrawi MH","year":"2013","unstructured":"El-Shabrawi MH, Kamal NM. Burden of pediatric hepatitis C. World J Gastroenterol. 2013, 19:7880-7888. 10.3748\/wjg.v19.i44.7880","journal-title":"World J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2000.02108.x","article-title":"Transmission of hepatitis C virus in Asia: past and present perspectives","volume":"15","author":"Kao JH","year":"2000","unstructured":"Kao JH, Chen DS. Transmission of hepatitis C virus in Asia: past and present perspectives. J Gastroenterol Hepatol. 2000, 15:E91-E96. 10.1046\/j.1440-1746.2000.02108.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30046-9","article-title":"Hepatitis C virus infection in children and adolescents","volume":"4","author":"Indolfi G","year":"2019","unstructured":"Indolfi G, Easterbrook P, Dusheiko G, et al.. Hepatitis C virus infection in children and adolescents. Lancet Gastroenterol Hepatol. 2019, 4:477-487. 10.1016\/S2468-1253(19)30046-9","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000001872","article-title":"Treatment of chronic hepatitis C virus infection in children: a position paper by the Hepatology Committee of European Society of Paediatric Gastroenterology, Hepatology and Nutrition","volume":"66","author":"Indolfi G","year":"2018","unstructured":"Indolfi G, Hierro L, Dezsofi A, et al.. Treatment of chronic hepatitis C virus infection in children: a position paper by the Hepatology Committee of European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2018, 66:505-515. 10.1097\/MPG.0000000000001872","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2019.0058","article-title":"Prevalence of hepatitis C virus genotypes in Pakistan: current scenario and review of literature","volume":"32","author":"Haqqi A","year":"2019","unstructured":"Haqqi A, Munir R, Khalid M, et al.. Prevalence of hepatitis C virus genotypes in Pakistan: current scenario and review of literature. Viral Immunol. 2019, 32:402-413. 10.1089\/vim.2019.0058","journal-title":"Viral Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29278","article-title":"Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection","volume":"66","author":"Wirth S","year":"2017","unstructured":"Wirth S, Rosenthal P, Gonzalez-Peralta RP, et al.. Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection. Hepatology. 2017, 66:1102-1110. 10.1002\/hep.29278","journal-title":"Hepatology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30821","article-title":"Sofosbuvir and ribavirin therapy for children aged 3 to <12 years with hepatitis C virus genotype 2 or 3 infection","volume":"71","author":"Rosenthal P","year":"2020","unstructured":"Rosenthal P, Schwarz KB, Gonzalez-Peralta RP, et al.. Sofosbuvir and ribavirin therapy for children aged 3 to &lt;12 years with hepatitis C virus genotype 2 or 3 infection. Hepatology. 2020, 71:31-43. 10.1002\/hep.30821","journal-title":"Hepatology"},{"key":"ref9","article-title":"Effectiveness and safety of sofosbuvir in treatment-naive children with hepatitis C infection","volume":"27","author":"Hashmi M","year":"2017","unstructured":"Hashmi M, Cheema H. Effectiveness and safety of sofosbuvir in treatment-naive children with hepatitis C infection. JCPSP. 2017, 27:423-426.","journal-title":"JCPSP"},{"key":"ref10","unstructured":"HCV Guidance. Recommendations for Testing, Managing, and Treating Hepatitis C. Accessed: August 27, 2020: http:\/\/www.hcvguidelines.org\/."},{"key":"ref11","unstructured":"Guidelines for the screening, care and treatment of persons with hepatitis C infection. (2014). Accessed. September 20, 2017: http:\/\/www.who.int\/hiv\/pub\/hepatitis\/hepatitis-c-guidelines\/en\/."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S2055-6640(20)30500-8","article-title":"Treating hepatitis C virus in children: time for a new paradigm","volume":"1","author":"Thorne C","year":"2015","unstructured":"Thorne C, Indolfi G, Turkova A, Giaquinto C, Nastouli E. Treating hepatitis C virus in children: time for a new paradigm. J Virus Erad. 2015, 1:203-205. 10.1016\/S2055-6640(20)30500-8","journal-title":"J Virus Erad"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20661","article-title":"Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C","volume":"41","author":"Wirth S","year":"2005","unstructured":"Wirth S, Pieper-Boustani H, Lang T, et al.. Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C. Hepatology. 2005, 41:1013-1018. 10.1002\/hep.20661","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318159836c","article-title":"Efficacy and safety of peginterferon-\u03b12b and ribavirin combination therapy in children with chronic hepatitis C infection","volume":"27","author":"Jara P","year":"2008","unstructured":"Jara P, Hierro L, de la Vega A, et al.. Efficacy and safety of peginterferon-\u03b12b and ribavirin combination therapy in children with chronic hepatitis C infection. Pediatr Infect Dis J. 2008, 27:142-148. 10.1097\/INF.0b013e318159836c","journal-title":"Pediatr Infect Dis J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.01.028","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in children and adolescents","volume":"52","author":"Sokal EM","year":"2010","unstructured":"Sokal EM, Bourgois A, St\u00e9phenne X, et al.. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in children and adolescents. J Hepatol. 2010, 52:827-831. 10.1016\/j.jhep.2010.01.028","journal-title":"J Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001316","article-title":"Long-term follow-up after cure from chronic hepatitis C virus infection shows occult hepatitis and a risk of hepatocellular carcinoma in noncirrhotic patients","volume":"31","author":"Lybeck C","year":"2019","unstructured":"Lybeck C, Brennd\u00f6rfer ED, S\u00e4llberg M, Montgomery SM, Aleman S, Duberg AS. Long-term follow-up after cure from chronic hepatitis C virus infection shows occult hepatitis and a risk of hepatocellular carcinoma in noncirrhotic patients. Eur J Gastroenterol Hepatol. 2019, 31:506-513. 10.1097\/MEG.0000000000001316","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840210243","article-title":"Variability of hepatitis C virus","volume":"21","author":"Simmonds P","year":"1995","unstructured":"Simmonds P. Variability of hepatitis C virus. Hepatology. 1995, 21:570-583. 10.1002\/hep.1840210243","journal-title":"Hepatology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/80147-outcome-of-treatment-in-children-with-chronic-viral-hepatitis-c-a-single-centre-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:38Z","timestamp":1707507698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/80147-outcome-of-treatment-in-children-with-chronic-viral-hepatitis-c-a-single-centre-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.21073","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,10]]}}}